Levels Diagnostics
Levels Diagnostics conducts biomarker discovery through clinical trials and proteomic screening, with a focus on developing diagnostic tests for early detection of liver cancer.
The company performs biomarker discovery using state-of-the-art proteomic screening and in-house statistical analysis with clinical trial experts. Levels Diagnostics is developing diagnostic tests for early detection of liver cancer, founded by scientists specializing in chemistry, biology, immunology, and molecular biology.
Key People
- Mark Schoonderwoerd - Co-founder
Blandine le Tallec - Co-founder
Coen Breedveld - Co-founder